Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vericel Corp | Director | Common Stock | 11K | $455K | $41.36 | Oct 16, 2024 | Direct |
Akebia Therapeutics, Inc. | Director | Common Stock | 117K | $148K | $1.26 | Jun 6, 2024 | Direct |
SCYNEXIS INC | Director | Common Stock | 47K | $76.6K | $1.63 | Jun 20, 2024 | Direct |
Vericel Corp | Director | Restricted Stock Unit | 3.2K | $57.6K | $18.00 | May 1, 2024 | Direct |
Akebia Therapeutics, Inc. | Director | Stock Option (Right to buy) | 45K | Jun 6, 2024 | Direct | ||
CONTRAFECT Corp | Director | Options (Right to Buy) | 42K | May 17, 2022 | Direct | ||
SCYNEXIS INC | Director | Stock Option | 23K | Jun 20, 2024 | Direct | ||
Vericel Corp | Director | Stock Option (Right to Buy) | 0 | Oct 16, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VCEL | Vericel Corp | Oct 16, 2024 | 3 | -$165K | 4 | Oct 18, 2024 | Director |
VCEL | Vericel Corp | Oct 2, 2024 | 3 | -$159K | 4 | Oct 4, 2024 | Director |
VCEL | Vericel Corp | Sep 18, 2024 | 3 | -$190K | 4 | Sep 20, 2024 | Director |
VCEL | Vericel Corp | Sep 4, 2024 | 3 | -$224K | 4 | Sep 5, 2024 | Director |
SCYX | SCYNEXIS INC | Jun 20, 2024 | 2 | $0 | 4 | Jun 21, 2024 | Director |
AKBA | Akebia Therapeutics, Inc. | Jun 6, 2024 | 2 | $0 | 4 | Jun 10, 2024 | Director |
VCEL | Vericel Corp | May 1, 2024 | 4 | $0 | 4 | May 3, 2024 | Director |
SCYX | SCYNEXIS INC | Jun 15, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
SCYX | SCYNEXIS INC | Jun 15, 2023 | 1 | $0 | 4 | Jun 20, 2023 | Director |
AKBA | Akebia Therapeutics, Inc. | Jun 6, 2023 | 2 | $0 | 4 | Jun 8, 2023 | Director |
VCEL | Vericel Corp | May 3, 2023 | 2 | $0 | 4 | May 5, 2023 | Director |
VCEL | Vericel Corp | Apr 27, 2023 | 2 | $0 | 4 | Apr 28, 2023 | Director |
SCYX | SCYNEXIS INC | Jun 17, 2022 | 2 | $0 | 4 | Jun 22, 2022 | Director |
AKBA | Akebia Therapeutics, Inc. | Jun 8, 2022 | 2 | $0 | 4 | Jun 9, 2022 | Director |
AKBA | Akebia Therapeutics, Inc. | Jun 3, 2022 | 1 | -$1.65K | 4 | Jun 7, 2022 | Director |
CFRX | CONTRAFECT Corp | May 17, 2022 | 1 | $141K | 4 | May 18, 2022 | Director |
VCEL | Vericel Corp | Apr 29, 2022 | 1 | -$27.8K | 4 | May 2, 2022 | Director |
VCEL | Vericel Corp | Apr 27, 2022 | 4 | $0 | 4 | Apr 29, 2022 | Director |
VCEL | Vericel Corp | Nov 29, 2021 | 3 | -$177K | 4 | Dec 1, 2021 | Director |
VCEL | Vericel Corp | Oct 27, 2021 | 3 | -$234K | 4 | Oct 28, 2021 | Director |
VCEL | Vericel Corp | Sep 30, 2021 | 3 | -$226K | 4 | Oct 1, 2021 | Director |
SCYX | SCYNEXIS INC | Jun 16, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
AKBA | Akebia Therapeutics, Inc. | Jun 7, 2021 | 1 | -$15.2K | 4 | Jun 9, 2021 | Director |
AKBA | Akebia Therapeutics, Inc. | Jun 2, 2021 | 2 | $0 | 4 | Jun 3, 2021 | Director |
CFRX | CONTRAFECT Corp | May 18, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |